Sideroblastic anemia natural history, complications and prognosis

Jump to navigation Jump to search

Sideroblastic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sideroblastic Anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sideroblastic anemia natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sideroblastic anemia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sideroblastic anemia natural history, complications and prognosis

CDC on Sideroblastic anemia natural history, complications and prognosis

Sideroblastic anemia natural history, complications and prognosis in the news

Blogs on Sideroblastic anemia natural history, complications and prognosis

Directions to Hospitals Treating Sideroblastic anemia

Risk calculators and risk factors for Sideroblastic anemia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nazia Fuad M.D.


Overview

Majority of patients of sideroblastic anemia at the time of diagnosis shows erythroid abnormalities and ineffective erythropoiesis. Granulocytic and megakaryocytic cell lines involvement is also common. In the initial stages bone marrow reveal erythroid expansion with ineffective erythropoiesis. Progression to bone marrow failure occurs in the course of the disease. The next phase in natural history of sideroblastic anemia is iron overload and evolution to nonlymphocytic leukemia. complications of sideroblastic anemia include secondry hemochromatosis, thrombocytopenia, Growth retardation, Blindness, Ineffective erythropoiesis, myocardial siderosis, liver cirrhosis and malabsorption. Prognosis depends on the type and cause of sideroblastic anemia. Sideroblastic anemia secondry to drugs or alcohol as underlying cause is associated with the most favorable prognosis. Sideroblastic anemias associated with MDS undergo leukemic transformation in 5-10% cases. The transfusion dependent are at risk of death from the complications of secondary hemochromatosis.

Natural History

  • Majority of patients of sideroblastic anemia at the time of diagnosis shows erythroid abnormalities and ineffective erythropoiesis.
  • Granulocytic and megakaryocytic cell lines involvement is also common.
  • In the initial stages bone marrow reveal erythroid expansion with ineffective erythropoiesis.
  • Progression to bone marrow failure occurs in the course of the disease.
  • The next phase in natural history of sideroblastic anemia is iron overload and evolution to nonlymphocytic leukemia.
  • The most common causes of death are related to complications of iron overload and evolution into ANLL.[1]

Complications

Common complications of sideroblastic anemia include

Prognosis

  • Depending on the type of sideroblastic anemia the prognosis may vary. However, the prognosis is generally regarded as good[1].
  • Sideroblastic anemia secondry to drugs or alcohol as underlying cause is associated with the most favorable prognosis.
  • (5-10%) of Severe refractory sideroblastic anemias associated with MDS undergo leukemic transformation.
  • AML markedly reduce life expectancy
  • Patients who do not need blood transfusions are likely to be long-term survivors.
  • The transfusion dependent are at risk of death from the complications of secondary hemochromatosis.

References

  1. 1.0 1.1 Cazzola M, Barosi G, Gobbi PG, Invernizzi R, Riccardi A, Ascari E (February 1988). "Natural history of idiopathic refractory sideroblastic anemia". Blood. 71 (2): 305–12. PMID 3337899.

Template:WH Template:WS